October 11, 2024 01:41 PM EDT
Deals
Pharma

Sanofi lands on pri­vate eq­ui­ty firm CD&R as po­ten­tial buy­er of con­sumer health unit

Max Bayer

Pharma Reporter

Sanofi has cho­sen US pri­vate eq­ui­ty firm Clay­ton, Du­bili­er & Rice to ad­vance ac­qui­si­tion talks for its con­sumer health unit, the phar­ma con­firmed Fri­day. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times